Two of the country’s largest independent infusion services providers recently unveiled that they have entered into a merger agreement. After coming together, BioScrip, Inc. and Option Care Enterprises, Inc. would be the No. 2 home/alternate site infusion provider in the United States, boosting their ability to get both manufacturer and payer contracts.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.